Novel influenza-like virus sequences previously identified in fish and amphibians were found to cluster as a sister clade of influenza B viruses, but have thus far remained uncharacterized.

Frequency, phenotype and T-cell receptor (TCR) composition of influenza-specific CD8+ T-cells directed at the prominent A2/M158 influenza epitope change across the human lifespan.

This strategy aims for 95% of individuals infected with HIV to know their status, 95% of those infected to be under effective treatment, and 95% of those receiving treatment to achieve viral suppression.

Anti-influenza therapeutics remain essential for the control of influenza infections, which may require hospitalization for the most severe cases.

The two influenza B virus (FLUBV) lineages have continuously diverged from each other since the 1980s, with recent (post-2015) viruses exhibiting accelerated evolutionary rate.

Six ESWI Board Members, led by Prof. Florian Krammer, together with a long list of prominent European scientists specialised in virology, immunology and epidemiology, have recently published a commentary in The Lancet Infectious Diseases.

This commentary highlights the potential need to incorporate neuraminidase components into future influenza vaccines

Estimates of current mid-season flu vaccine effectiveness (VE) in Europe and China range from 32% to 58% overall, with greater protection against influenza B than A, according to three studies published in Eurosurveillance.